ZELOXZAR Trademark

Trademark Overview

On Thursday, December 20, 2012, a trademark application was filed for ZELOXZAR with the United States Patent and Trademark Office. The USPTO has given the ZELOXZAR trademark a serial number of 85807834. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 8, 2022. This trademark is owned by AstraZeneca AB. The ZELOXZAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation
zeloxzar

General Information

Serial Number85807834
Word MarkZELOXZAR
Filing DateThursday, December 20, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 8, 2022
Registration Number4820405
Registration DateTuesday, September 29, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 9, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, nervous system diseases and disorders, infection and inflammation

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 8, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAstraZeneca AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE
Party NameAstraZeneca AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSödertälje SE-15185
SE

Trademark Events

Event DateEvent Description
Friday, April 8, 2022CANCELLED SEC. 8 (6-YR)
Thursday, July 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, July 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, July 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, July 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 29, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, February 8, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 29, 2015REGISTERED-PRINCIPAL REGISTER
Monday, August 24, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Wednesday, July 15, 2015NOTICE OF ALLOWANCE CANCELLED
Sunday, August 23, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 15, 2015TEAS DELETE 1(B) BASIS RECEIVED
Tuesday, February 3, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 9, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 9, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 19, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 5, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, October 30, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 29, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 29, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 22, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, May 17, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, May 17, 2014NON-FINAL ACTION E-MAILED
Saturday, May 17, 2014NON-FINAL ACTION WRITTEN
Friday, April 25, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 25, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 21, 2014ASSIGNED TO LIE
Wednesday, April 2, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 2, 2013NON-FINAL ACTION E-MAILED
Wednesday, October 2, 2013NON-FINAL ACTION WRITTEN
Wednesday, September 11, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 11, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 11, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, March 24, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sunday, March 24, 2013NON-FINAL ACTION E-MAILED
Sunday, March 24, 2013NON-FINAL ACTION WRITTEN
Friday, March 22, 2013ASSIGNED TO EXAMINER
Tuesday, January 8, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, December 24, 2012NEW APPLICATION ENTERED IN TRAM

Related Keywords

zeloxzar diseases disorders substances preparations pharmaceutical nervous system inflammation infection gastrointestinal